[1] |
AFARI Z,LYND L D,FITZGERALD J M,et al. Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma:a simulation study[J]. J Allergy Clin Immunol,2014,134(4):908-915.e3. DOI:10.1016/j.jaci.2014.04.009.
|
[2] |
DAVIS K L,EDIN H M,ALLEN J K. Prevalence and cost of medication nonadherence in Parkinson's disease:evidence from administrative claims data[J]. Mov Disord,2010,25(4):474-480. DOI:10.1002/mds.22999.
|
[3] |
FORMICA D,SULTANA J,CUTRONEO P M,et al. The economic burden of preventable adverse drug reactions:a systematic review of observational studies[J]. Expert Opin Drug Saf,2018,17(7):681-695. DOI:10.1080/14740338.2018.1491547.
|
[4] |
PIRMOHAMED M,JAMES S,MEAKIN S,et al. Adverse drug reactions as cause of admission to hospital:prospective analysis of 18 820 patients[J]. BMJ,2004,329(7456):15-19. DOI:10.1136/bmj.329.7456.15.
|
[5] |
HANDELMAN G S,KOK H K,CHANDRA R V,et al. eDoctor:machine learning and the future of medicine[J]. J Intern Med,2018,284(6):603-619. DOI:10.1111/joim.12822.
|
[6] |
JARRETT D,STRIDE E,VALLIS K,et al. Applications and limitations of machine learning in radiation oncology[J]. Br J Radiol,2019,92(1100):20190001. DOI:10.1259/bjr.20190001.
|
[7] |
BZDOK D,KRZYWINSKI M,ALTMAN N. Machine learning:supervised methods[J]. Nat Methods,2018,15(1):5-6. DOI:10.1038/nmeth.4551.
|
[8] |
BI Q F,GOODMAN K E,KAMINSKY J,et al. What is machine learning? A primer for the epidemiologist[J]. Am J Epidemiol,2019,188(12):2222-2239. DOI:10.1093/aje/kwz189.
|
[9] |
ESTEVA A,ROBICQUET A,RAMSUNDAR B,et al. A guide to deep learning in healthcare[J]. Nat Med,2019,25(1):24-29. DOI:10.1038/s41591-018-0316-z.
|
[10] |
SUO Q L,MA F L,YUAN Y,et al. Deep patient similarity learning for personalized healthcare[J]. IEEE Trans Nanobioscience,2018,17(3):219-227. DOI:10.1109/TNB.2018.2837622.
|
[11] |
CHENG Y T,LIN Y F,CHIANG K H,et al. Mining sequential risk patterns from large-scale clinical databases for early assessment of chronic diseases:a case study on chronic obstructive pulmonary disease[J]. IEEE J Biomed Health Inform,2017,21(2):303-311. DOI:10.1109/JBHI.2017.2657802.
|
[12] |
WRIGHT A P,WRIGHT A T,MCCOY A B,et al. The use of sequential pattern mining to predict next prescribed medications[J]. J Biomed Inform,2015,53:73-80. DOI:10.1016/j.jbi.2014.09.003.
|
[13] |
BEAM A L,KARTOUN U,PAI J K,et al. Predictive modeling of physician-patient dynamics that influence sleep medication prescriptions and clinical decision-making[J]. Sci Rep,2017,7:42282. DOI:10.1038/srep42282.
|
[14] |
YELIN I,SNITSER O,NOVICH G,et al. Personal clinical history predicts antibiotic resistance of urinary tract infections[J]. Nat Med,2019,25(7):1143-1152. DOI:10.1038/s41591-019-0503-6.
|
[15] |
ROUGH K,DAI A M,ZHANG K,et al. Predicting inpatient medication orders from electronic health record data[J]. Clin Pharmacol Ther,2020,108(1):145-154. DOI:10.1002/cpt.1826.
|
[16] |
朱立强,王勇敢,李卫华,等. 采用机器学习方法建立Ⅰ类切口手术患者使用抗菌药物合理性的评价模型[J]. 中国药房,2019,30(9):1260-1265. DOI:10.6039/j.issn.1001-0408.2019.09.22.
|
[17] |
MA Z,WANG P,GAO Z,et al. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose[J]. PLoS One,2018,13(10):e0205872. DOI:10.1371/journal.pone.0205872.
|
[18] |
ROCHE-LIMA A,ROMAN-SANTIAGO A,FELIU-MALDONADO R,et al. Machine learning algorithm for predicting warfarin dose in Caribbean hispanics using pharmacogenetic data[J]. Front Pharmacol,2019,10:1550. DOI:10.3389/fphar.2019.01550.
|
[19] |
TAO Y Y,CHEN Y J,FU X Y,et al. Evolutionary ensemble learning algorithm to modeling of warfarin dose prediction for Chinese[J]. IEEE J Biomed Health Inform,2019,23(1):395-406. DOI:10.1109/JBHI.2018.2812165.
|
[20] |
SU L X,LIU C,LI D K,et al. Toward optimal heparin dosing by comparing multiple machine learning methods:retrospective study[J]. JMIR Med Inform,2020,8(6):e17648. DOI:10.2196/17648.
|
[21] |
LEVY A E,BISWAS M,WEBER R,et al. Applications of machine learning in decision analysis for dose management for dofetilide[J]. PLoS One,2019,14(12):e0227324. DOI:10.1371/journal.pone.0227324.
|
[22] |
NIKFARJAM A,GONZALEZ G H. Pattern mining for extraction of mentions of Adverse Drug Reactions from user comments[J]. AMIA Annu Symp Proc,2011,2011:1019-1026.
|
[23] |
PATKI A,SARKER A,PIMPALKHUTE P,et al. Mining adverse drug reaction signals from social media:going beyond extraction[C]. BioLink-SIG,2014.
|
[24] |
JAMAL S,GOYAL S,SHANKER A,et al. Predicting neurological Adverse Drug Reactions based on biological,chemical and phenotypic properties of drugs using machine learning models[J]. Sci Rep,2017,7(1):1-12. DOI:10.1038/s41598-017-00908-z.
|
[25] |
HAMMANN F,SCHÖNING V,DREWE J. Prediction of clinically relevant drug-induced liver injury from structure using machine learning[J]. J Appl Toxicol,2019,39(3):412-419. DOI:10.1002/jat.3741.
|
[26] |
FENG C L,CHEN H W,YUAN X Q,et al. Gene expression data based deep learning model for accurate prediction of drug-induced liver injury in advance[J]. J Chem Inf Model,2019,59(7):3240-3250. DOI:10.1021/acs.jcim.9b00143.
|
[27] |
LAI N H,SHEN W C,LEE C N,et al. Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniques[J]. Comput Methods Programs Biomed,2020,188(2):105307. DOI:10.1016/j.cmpb.2019.105307.
|
[28] |
DAVAZDAHEMAMI B,DELEN D. A chronological pharmacovigilance network analytics approach for predicting adverse drug events[J]. J Am Med Inform Assoc,2018,25(10):1311-1321. DOI:10.1093/jamia/ocy097.
|
[29] |
CHEKROUD A M,ZOTTI R J,SHEHZAD Z,et al. Cross-trial prediction of treatment outcome in depression:a machine learning approach[J]. Lancet Psychiatry,2016,3(3):243-250. DOI:10.1016/S2215-0366(15)00471-X.
|
[30] |
ATHREYA A P,NEAVIN D,CARRILLO-ROA T,et al. Pharmacogenomics-driven prediction of antidepressant treatment outcomes:a machine-learning approach with multi-trial replication[J]. Clin Pharmacol Ther,2019,106(4):855-865. DOI:10.1002/cpt.1482.
|
[31] |
SAKELLAROPOULOS T,VOUGAS K,NARANG S,et al. A deep learning framework for predicting response to therapy in cancer[J]. Cell Rep,2019,29(11):3367-3373.e4. DOI:10.1016/j.celrep.2019.11.017.
|
[32] |
JIANG Y M,LIU W,LI T J,et al. Prognostic and predictive value of p21-activated kinase 6 associated support vector machine classifier in gastric cancer treated by 5-fluorouracil/oxaliplatin chemotherapy[J]. EBioMedicine,2017,22:78-88. DOI:10.1016/j.ebiom.2017.06.028.
|
[33] |
MACESIC N,POLUBRIAGINOF F,TATONETTI N P. Machine learning:novel bioinformatics approaches for combating antimicrobial resistance[J]. Curr Opin Infect Dis,2017,30(6):511-517. DOI:10.1097/QCO.0000000000000406.
|
[34] |
DAVIS J J,BOISVERT S,BRETTIN T,et al. Antimicrobial resistance prediction in PATRIC and RAST[J]. Sci Rep,2016,6:27930. DOI:10.1038/srep27930.
|
[35] |
CHOWDHURY A S,KHALEDIAN E,BROSCHAT S L. Capreomycin resistance prediction in two species of Mycobacterium using a stacked ensemble method[J]. J Appl Microbiol,2019,127(6):1656-1664. DOI:10.1111/jam.14413.
|
[36] |
MANCINI A,VITO L,MARCELLI E,et al. Machine learning models predicting multidrug resistant urinary tract infections using "DsaaS" [J]. BMC Bioinformatics,2020,21():347. DOI:10.1186/s12859-020-03566-7.
|
[37] |
AN S,MALHOTRA K,DILLEY C,et al. Predicting drug-resistant epilepsy-A machine learning approach based on administrative claims data[J]. Epilepsy Behav,2018,89:118-125. DOI:10.1016/j.yebeh.2018.10.013.
|
[38] |
DORMAN S N,BARANOVA K,KNOLL J H,et al. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning[J]. Mol Oncol,2016,10(1):85-100. DOI:10.1016/j.molonc.2015.07.006.
|
[39] |
CHENG F X,ZHAO Z M. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic,therapeutic,chemical,and genomic properties[J]. J Am Med Inform Assoc,2014,21(e2):e278-286. DOI:10.1136/amiajnl-2013-002512.
|
[40] |
KASTRIN A,FERK P,LESKOŠEK B. Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning[J]. PLoS One,2018,13(5):e0196865. DOI:10.1371/journal.pone.0196865.
|
[41] |
RYU J Y,KIM H U,LEE S Y. Deep learning improves prediction of drug-drug and drug-food interactions[J]. Proc Natl Acad Sci USA,2018,115(18):E4304-4311. DOI:10.1073/pnas.1803294115.
|
[42] |
TUCKER C S,BEHOORA I,NEMBHARD H B,et al. Machine learning classification of medication adherence in patients with movement disorders using non-wearable sensors[J]. Comput Biol Med,2015,66:120-134. DOI:10.1016/j.compbiomed.2015.08.012.
|
[43] |
MOHEBBI A,ARADÓTTIR T B,JOHANSEN A R,et al. A deep learning approach to adherence detection for type 2 diabetics[J].Annu Int Conf IEEE Eng Med Biol Soc,2017,2017:2896-2899. DOI:10.1109/EMBC.2017.8037462.
|
[44] |
LI Y,JASANI F,SU D,et al. Decoding nonadherence to hypertensive medication in New York City:a population segmentation approach[J]. J Prim Care Community Health,2019,10:2150132719829311. DOI:10.1177/2150132719829311.
|
[45] |
WU X W,YANG H B,YUAN R,et al. Predictive models of medication non-adherence risks of patients with T2D based on multiple machine learning algorithms[J]. BMJ Open Diabetes Res Care,2020,8(1):e001055. DOI:10.1136/bmjdrc-2019-001055.
|